Engineers Gate Manager’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,044
Closed -$96K 1843
2022
Q3
$96K Buy
3,044
+1,680
+123% +$70.3K 0.01% 1455
2022
Q2
$47K Buy
+1,364
New +$87.4K ﹤0.01% 1792
2022
Q1
Sell
-1,163
Closed -$111K 2064
2021
Q4
$111K Sell
1,163
-2,345
-67% -$211K 0.01% 1795
2021
Q3
$310K Buy
3,508
+2,018
+135% +$199K 0.02% 1168
2021
Q2
$183K Sell
1,490
-304
-17% -$42.1K 0.01% 1425
2021
Q1
$286K Buy
+1,794
New +$304K 0.01% 1351

Other funds holding IMUX

Engineers Gate Manager's IMUX Position: Q4 2022 in Review

Engineers Gate Manager sold out of Immunic (IMUX) in Q4 2022, closing a stake of 3,044 shares — an estimated $96K sold.

Engineers Gate Manager first reported a position in IMUX in Q1 2021 and held it in 6 quarters. The position peaked at $310K in Q3 2021. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

  • Engineers Gate Manager reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 3,044 Immunic shares in Q4 2022, an estimated $96K.
  • Engineers Gate Manager first reported a position in Immunic in Q1 2021 and held it in 6 quarters.
  • Engineers Gate Manager's Immunic position peaked at $310K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Engineers Gate Manager's 13F filing for Q4 2022, filed 14 Feb 2023.